Aprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center ...

Head and neck oncology is a multifaceted field that integrates the expertise of various specialists including otorhinolaryngologists, oncologists, ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

From penile cancer to oropharyngeal cancer, know the health risks of HPV for men’s health. The expert emphasised on the need ...

Community members share their immunization stories ahead of a free HPV vaccine clinic being held at Harwood Union MS/HS on March 12.

We are thrilled to share that the first trial site has been initiated and activation of additional clinical sites continues,” said Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS ...

PDS Biotechnology (PDSB) announced the initiation of the VERSATILE-003 Phase 3 clinical trial. The trial is now open to patient enrollment.

Researchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...

Chemotherapy and immunotherapy followed by de-escalated chemoradiation showed increased survival and reduced side effects in aggressive head and neck cancers that are not associated with human ...

While the human papillomavirus (HPV) is most associated with cervical cancer risk and women, a new survey commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer ...

HPV isn't just a concern for women — it’s actually more common in men and is driving a rise in dangerous cancers, including ...